Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

R. Nave, Rüdiger Nave, Stefan Jodl, Anja Hoffmann, Isabella Gashaw, Frank S. Zollmann, Frank Zollmann, Matthias Berse, Joachim Höchel, Jörn Krätzschmar, Beate Rohde
Reproductive sciences (Thousand Oaks, Calif.) · 2018 · vol. 26(4) , pp. 523–531 · doi:10.1177/1933719118776806 · PMID:29806538 · W2805739188
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Antibodies, Monoclonal Receptors, Prolactin Antibodies, Monoclonal Antibodies, Monoclonal Drug Administration Schedule Endometriosis Endometriosis Female Humans Injections, Subcutaneous Middle Aged Postmenopause Receptors, Prolactin Receptors, Prolactin

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (3)

References (29)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:19:49.066213+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK